NEOGENOMICS INC (NEO) Stock Fundamental Analysis
NASDAQ:NEO - Nasdaq - US64049M2098 - Common Stock - Currency: USD
Taking everything into account, NEO scores 3 out of 10 in our fundamental rating. NEO was compared to 102 industry peers in the Health Care Providers & Services industry. NEO may be in some trouble as it scores bad on both profitability and health. NEO is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
NEO had positive earnings in the past year.
In the past year NEO had a positive cash flow from operations.
In the past 5 years NEO reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: NEO reported negative operating cash flow in multiple years.
1.2 Ratios
NEO has a worse Return On Assets (-4.81%) than 69.61% of its industry peers.
The Return On Equity of NEO (-8.72%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.81% | ||
| ROE | -8.72% | ||
| ROIC | N/A |
ROA(3y)-6.11%
ROA(5y)-3.67%
ROE(3y)-10.84%
ROE(5y)-6.53%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
NEO has a better Gross Margin (43.92%) than 73.53% of its industry peers.
In the last couple of years the Gross Margin of NEO has declined.
NEO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.92% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.37%
GM growth 5Y-1.82%
2. Health
2.1 Basic Checks
NEO does not have a ROIC to compare to the WACC, probably because it is not profitable.
NEO has more shares outstanding than it did 1 year ago.
NEO has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NEO is higher compared to a year ago.
2.2 Solvency
NEO has an Altman-Z score of 1.21. This is a bad value and indicates that NEO is not financially healthy and even has some risk of bankruptcy.
NEO's Altman-Z score of 1.21 is on the low side compared to the rest of the industry. NEO is outperformed by 69.61% of its industry peers.
A Debt/Equity ratio of 0.38 indicates that NEO is not too dependend on debt financing.
NEO has a better Debt to Equity ratio (0.38) than 61.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.21 |
ROIC/WACCN/A
WACC6.18%
2.3 Liquidity
A Current Ratio of 1.98 indicates that NEO should not have too much problems paying its short term obligations.
The Current ratio of NEO (1.98) is better than 73.53% of its industry peers.
NEO has a Quick Ratio of 1.89. This is a normal value and indicates that NEO is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.89, NEO is doing good in the industry, outperforming 73.53% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.89 |
3. Growth
3.1 Past
NEO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 190.91%, which is quite impressive.
Measured over the past years, NEO shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -20.25% on average per year.
Looking at the last year, NEO shows a quite strong growth in Revenue. The Revenue has grown by 11.65% in the last year.
NEO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.07% yearly.
EPS 1Y (TTM)190.91%
EPS 3YN/A
EPS 5Y-20.25%
EPS Q2Q%33.33%
Revenue 1Y (TTM)11.65%
Revenue growth 3Y10.9%
Revenue growth 5Y10.07%
Sales Q2Q%10.57%
3.2 Future
NEO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 81.65% yearly.
The Revenue is expected to grow by 11.58% on average over the next years. This is quite good.
EPS Next Y82.07%
EPS Next 2Y86.9%
EPS Next 3Y81.65%
EPS Next 5YN/A
Revenue Next Year11.7%
Revenue Next 2Y11.44%
Revenue Next 3Y11.58%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 65.80, NEO can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as NEO.
Compared to an average S&P500 Price/Earnings ratio of 28.98, NEO is valued quite expensively.
A Price/Forward Earnings ratio of 36.14 indicates a quite expensive valuation of NEO.
NEO's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.38, NEO is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 65.8 | ||
| Fwd PE | 36.14 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
NEO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NEO's earnings are expected to grow with 81.65% in the coming years.
PEG (NY)0.8
PEG (5Y)N/A
EPS Next 2Y86.9%
EPS Next 3Y81.65%
5. Dividend
5.1 Amount
NEO does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
6.58
-3.39 (-34%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.16%
Inst Owner Change0.02%
Ins Owners1.14%
Ins Owner Change0.85%
Market Cap846.58M
Analysts80
Price Target18.53 (181.61%)
Short Float %3.91%
Short Ratio2.98
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)166.65%
Min EPS beat(2)35.03%
Max EPS beat(2)298.27%
EPS beat(4)4
Avg EPS beat(4)316.12%
Min EPS beat(4)35.03%
Max EPS beat(4)871.51%
EPS beat(8)8
Avg EPS beat(8)210.15%
EPS beat(12)12
Avg EPS beat(12)151.94%
EPS beat(16)15
Avg EPS beat(16)91.05%
Revenue beat(2)0
Avg Revenue beat(2)-1.09%
Min Revenue beat(2)-1.66%
Max Revenue beat(2)-0.51%
Revenue beat(4)2
Avg Revenue beat(4)0.42%
Min Revenue beat(4)-1.66%
Max Revenue beat(4)3.2%
Revenue beat(8)6
Avg Revenue beat(8)2.77%
Revenue beat(12)9
Avg Revenue beat(12)2.72%
Revenue beat(16)11
Avg Revenue beat(16)1.97%
PT rev (1m)-2.68%
PT rev (3m)-12.21%
EPS NQ rev (1m)-30.73%
EPS NQ rev (3m)-151.43%
EPS NY rev (1m)1.2%
EPS NY rev (3m)-7.84%
Revenue NQ rev (1m)-0.27%
Revenue NQ rev (3m)-0.62%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)1.46%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 65.8 | ||
| Fwd PE | 36.14 | ||
| P/S | 1.28 | ||
| P/FCF | N/A | ||
| P/OCF | 120.54 | ||
| P/B | 0.94 | ||
| P/tB | 21.22 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.1
EY1.52%
EPS(NY)0.18
Fwd EY2.77%
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)0.05
OCFY0.83%
SpS5.13
BVpS7.01
TBVpS0.31
PEG (NY)0.8
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.81% | ||
| ROE | -8.72% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.92% | ||
| FCFM | N/A |
ROA(3y)-6.11%
ROA(5y)-3.67%
ROE(3y)-10.84%
ROE(5y)-6.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.37%
GM growth 5Y-1.82%
F-Score6
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 56.6% | ||
| Cap/Sales | 6.22% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.89 | ||
| Altman-Z | 1.21 |
F-Score6
WACC6.18%
ROIC/WACCN/A
Cap/Depr(3y)46.9%
Cap/Depr(5y)68.48%
Cap/Sales(3y)5.71%
Cap/Sales(5y)7.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)190.91%
EPS 3YN/A
EPS 5Y-20.25%
EPS Q2Q%33.33%
EPS Next Y82.07%
EPS Next 2Y86.9%
EPS Next 3Y81.65%
EPS Next 5YN/A
Revenue 1Y (TTM)11.65%
Revenue growth 3Y10.9%
Revenue growth 5Y10.07%
Sales Q2Q%10.57%
Revenue Next Year11.7%
Revenue Next 2Y11.44%
Revenue Next 3Y11.58%
Revenue Next 5YN/A
EBIT growth 1Y11.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year159.76%
EBIT Next 3Y48.9%
EBIT Next 5YN/A
FCF growth 1Y-10.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y459.6%
OCF growth 3YN/A
OCF growth 5Y-21.37%